Browsing: statins

get-attachment (204)

‘Medical reports compiled on patients’ illnesses shows the cholesterol lowering drugs have been associated with a huge dossier of reported side-effects including irreversible muscle breakdown, muscle pain, blood disorders, diabetes, skin disorders, nervous system disorders and stomach problems over the last twenty years.

Between eight and ten million Britons take statins, the most widely prescribed drugs in the UK. However figures from the medicines’ watchdog have led to calls for an urgent review of the safety of statins with experts claiming the harm may outweigh any potential benefit in low risk patients.

The figures, compiled by this paper cast further doubt on NICE’s decision to lower the prescribing threshold so that the drugs are given to low risk patients and include up to 17 million patients, almost 40 percent of the adult population.’

Read more: Statins linked to 20,000 side effects and 227 deaths

Share.

‘The use of cholesterol-lowering statin drugs could double your risk of developing diabetes, suggests a study conducted by researchers from the VA North Texas Health System and the University of Texas Southwestern that was published in the Journal of General Internal Medicine on April 28.

Previous studies have shown a link between statin use and increased diabetes rates, but the new study is the first to show that statins seem to increase diabetes risk even in otherwise healthy people who are not predisposed to the disease.’

Read more: Statin drug use nearly doubles your risk of diabetes, study claims

Share.

‘Statins are a deadly scam, and new research published in the journal Expert Review of Clinical Pharmacology undoubtedly proves this. Using “statistical deception” to make statins appear safe and effective, the drug industry has deviously sold the United States and other Western nations a bill of goods, say researchers, as actual data shows that statins provide almost no benefits while causing serious harm.

Dr. David M. Diamond, a professor of psychology, molecular pharmacology and physiology at the University of South Florida, and Dr. Uffe Ravnskov, an independent health researcher and expert in cholesterol and cardiovascular disease, teamed up to a take a closer look at the claims made about statins. After reviewing a cohort of published studies on statins, they concluded that statistical trickery is responsible for their ill-gained notoriety.’

Read more: Big Pharma used 'statistical deception' to sell deadly statin scam to Americans, study concludes

Share.

‘Two studies recently published in the Expert Review of Clinical Pharmacology have drawn new attention to the fact that, far from being the miracle cure that was promised 20 years ago, statins actually carry serious side effects — and rather than reducing the risk of cardiovascular disease, they actually increase it!

The studies came in the same month that U.S. government’s top nutrition advisory panel decided to drop its warning about dietary cholesterol.

Statins function by inhibiting an enzyme necessary for the production of cholesterol in the body, and there is no doubt that they do indeed lower blood levels of cholesterol. Due to their striking short-term effects, statins were immediately and widely embraced by the medical establishment, and their use has ballooned ever since, with the threshold for their use continually dropping.’

Read more: Statin scam worsens cardiovascular disease epidemic

Share.

‘Potentially reversing almost 40 years of government policy, the top nutrition advisory board for the United States has dropped its warning against dietary cholesterol. The Dietary Guidelines Advisory Committee concluded that no evidence supports a link between dietary cholesterol and heart disease.

Even five years ago, the committee was still promoting the warning first popularized by the American Heart Association in 1961. But the new position has been a long time coming.

“There’s been a shift of thinking,” said Walter Willett, chair of the nutrition department at the Harvard School of Public Health. He called the committee’s decision to drop the cholesterol warning a “reasonable move.”‘

Read more: 'Settled' science was totally wrong yet again: Cholesterol in foods does not cause heart disease

Share.

‘Plans for the mass prescription of statins should be shelved after a study linked the drug to Parkinson’s disease, an expert last night warned.

Dr Kailash Chand, deputy chairman of the British Medical Association, was speaking following research which found those who take the cholesterol-lowering drugs are more than twice as likely to develop Parkinson’s disease in later life than those who do not.

A study last week showed statin use increases the risk of diabetes by 46 per cent.

It has led to calls to end to the widespread use of the drugs.’

Read more: Parkinson's link to statins: Calls to end widespread use of the drug

Share.

‘Statins prescribed to guard against heart attacks and strokes could increase the risk of diabetes by almost 50 per cent, a major trial suggests.

A six-year study from Finland on almost 9,000 men found that those prescribed the cholesterol-lowering drugs were far more likely to suffer from poor blood sugar control, and signs of diabetes.

Researchers found that after results were adjusted for age, body mass index, family history of diabetes, and smoking, alcohol and exercise habits, those on statins were 46 per cent more likely to develop diabetes.’

Read more: Statins increase risk of diabetes by almost 50 per cent, study finds

Share.

‘The cholesterol-lowering statin drug empire continues to crumble. This past Sunday (February 15, 2015) the Sunday Express in the UK published a headline story stating that Oxford professor Dr. Rory Collins, whose research had been used to support putting millions of patients on statin drugs, was reassessing the data behind those studies for possible drug side effects they might have missed previously.

According to the Express:

Although the original research looked at the effect of statins on the heart and considered cancer risks it did not examine other side effects.

This announcement by Dr. Collins is stunning, to say the least, and points to a massive cover-up and scandal related to statin drugs.’

Read more: Statin Drug Scandal: Cholesterol-lowering Drug Researchers Start Backtracking

Share.

‘The benefits of taking statins have been exaggerated, two leading experts claim.

They say the cholesterol-lowering medicines – hailed as miracle drugs when they hit the market 20 years ago – are not as safe or effective at preventing heart attacks as patients have been led to believe.

Although they can dramatically cut cholesterol levels, they have ‘failed to substantially improve cardiovascular outcomes’, says an analysis of data in clinical trials.

It was carried out by Dr David Diamond, a professor of molecular pharmacology at the University of South Florida, and expert in cardiovascular disease Dr Uffe Ravnskov.’

Read more: Have benefits of statins been exaggerated? Advocates distorted statistics and downplayed side-effects say experts

Share.

‘An Oxford professor whose findings were central to the mass prescription of statins is to re-examine trial data after concerns over the heart drug.

Prof Rory Collins, whose research helped rubber stamp statins as safe, said his team will carry out a “challenging” reassessment of the evidence which will include studying all reported side effects.

Although the original research looked at the effect of statins on the heart and considered cancer risks it did not examine other side effects.

Separate studies and patient complaints have included muscle pain, cataracts, diabetes, fatigue and memory loss. Dr Collins, who championed the controversial drug, said the additional work was needed to convince the public that statins were safe.’

Read more: Statins expert calls for safety checks over the drug

Share.
1 2 3